| Title |
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
|
|---|---|
| Published in |
CNS Drugs, September 2019
|
| DOI | 10.1007/s40263-019-00664-w |
| Pubmed ID | |
| Authors |
Ewa Galaj, Zheng-Xiong Xi |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 43% |
| Canada | 1 | 14% |
| Central African Republic | 1 | 14% |
| Unknown | 2 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 86% |
| Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 98 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 12 | 12% |
| Student > Bachelor | 12 | 12% |
| Researcher | 9 | 9% |
| Student > Master | 8 | 8% |
| Other | 7 | 7% |
| Other | 18 | 18% |
| Unknown | 32 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 15 | 15% |
| Neuroscience | 14 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 11% |
| Chemistry | 7 | 7% |
| Agricultural and Biological Sciences | 6 | 6% |
| Other | 12 | 12% |
| Unknown | 33 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 February 2020.
All research outputs
#4,776,781
of 23,096,849 outputs
Outputs from CNS Drugs
#451
of 1,317 outputs
Outputs of similar age
#95,153
of 344,617 outputs
Outputs of similar age from CNS Drugs
#9
of 20 outputs
Altmetric has tracked 23,096,849 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,317 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,617 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.